Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-IL-13RA2 Antibody-FITC (9B615)
😃Good
Catalog No. TMAY-00669F
Alias interleukin 13 receptor, α2, interleukin 13 receptor, alpha 2, CD213a2
Anti-IL-13RA2 Antibody-FITC (9B615) is a FITC-conjugated Rabbit antibody targeting IL-13RA2. Anti-IL-13RA2 Antibody-FITC (9B615) can be used in FCM.
Anti-IL-13RA2 Antibody-FITC (9B615)
Anti-IL-13RA2 Antibody-FITC (9B615)
😃Good
Catalog No. TMAY-00669FAlias interleukin 13 receptor, α2, interleukin 13 receptor, alpha 2, CD213a2
Anti-IL-13RA2 Antibody-FITC (9B615) is a FITC-conjugated Rabbit antibody targeting IL-13RA2. Anti-IL-13RA2 Antibody-FITC (9B615) can be used in FCM.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 T | $104 | 7-10 days | |
| 100 T | $327 | 7-10 days |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Antibody Type: Rabbit Monoclonal Application: FCM Reactivity: Human |
| Alias | interleukin 13 receptor, α2, interleukin 13 receptor, alpha 2, CD213a2 |
| Ig Type | Rabbit IgG |
| Clone | 9B615 |
| Reactivity | Human |
| Verified Activity | Flow cytometric analysis of Human IL13Ra2(CD213a2) expression on A375 cells. Cells were stained with FITC-conjugated anti-Human IL13Ra2(CD213a2). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. |
| Application | FCM |
| Recommended Dose | 10 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human IL13RA2 / CD213A2 (rh IL13RA2 / CD213A2; TMPY-00841; NP_000631.1; Met1-Leu342) and conjugated with FITC under optimum conditions, the unreacted FITC was removed. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
| Research Background | Interleukin-13 receptor subunit alpha-2 (IL13RA2/IL-13RA2) is also known as cluster of differentiation 213A2 (CD213A2), IL-13 receptor subunit alpha-2, IL-13R subunit alpha-2, and IL-13RA2. The IL13RA2 is often overexpressed in brain tumors, making Il13ra2 one of the vaccine targets for immunotherapy of glioma. IL13RA2/IL-13RA2 is a cancer-associated receptor that is present in greater than 80% of High-Grade Astrocytomas (HGA) and has recently been recognized as a cytokine that predisposes breast cancer cells to metastasize. Expression of IL13Rα2 was rapidly lost from the surface of transduced cells grown in culture. The loss appeared to be related to ligands present in fetal bovine serum in the medium. None of the malignant glioma cell lines cultivated in vitro and tested to date exhibited the IL13Rα2 receptor. A recombinant virus (R5111) enters cells via its interaction with the IL13Rα2 receptor in a manner that cannot be differentiated from the interaction of wild-type virus with its receptors. |
| Conjucates | FITC |
| Others Formats | Unconjugated/APC/PE |
| Antibody Types Available | 4 |
| Immunogen | Recombinant Protein: Human IL13RA2 / CD213A2 Protein (TMPY-00841) |
| Antigen Species | Human |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-IL-13RA2 Antibody-FITC (9B615) | purchase Anti-IL-13RA2 Antibody-FITC (9B615) | Anti-IL-13RA2 Antibody-FITC (9B615) cost | order Anti-IL-13RA2 Antibody-FITC (9B615)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.